PolyNovo UK Limited

About Us

At PolyNovo we are driven by improving the outcomes of patients through development and provision of the best surgical solutions possible.

PolyNovo develops innovative medical devices utilizing the patented bioabsorbable polymer technology Novosorb®.

NovoSorb is a family of proprietary medical grade polymers that can be expressed in a variety of physical formats. NovoSorb polymers have advantageous properties such as biocompatibility and design flexibility. These properties underpin novel medical devices designed to support tissue repair, before they biodegrade in situ into biocompatible by-products via established pathways.

NovoSorb BTM (Biodegradable Temporizing Matrix) is the first product commercialized by PolyNovo. In 2015, following the FDA 510(K) clearance of BTM, PolyNovo was awarded an $11 million contract and a further $25 million in funding from the US-based Biomedical Advanced Research and Development Authority (BARDA) to complete a trial with BTM for full thickness burns.

We have expanded our manufacturing facility and headquarters in Melbourne, Australia, establishing high quality processes, enabling product innovation and preparing for growth.

Useful Information

NovoSorb BTM product brochure

View document

Find us at an Event

Medica 2022
Dusseldorf, Germany
ABHI UK Pavilion - Hall 16, H48
14 Nov - 17 Nov 2022
Arab Health 2023
Dubai, UAE
ABHI UK Pavilion
30 Jan - 2 Feb 2023
Medica 2023
Messe Dusseldorf, Germany
Hall 16, K48.1 POD 6
13 Nov - 16 Nov 2023


10 John Street
United Kingdom
United Kingdom


Visit website


Let’s connect